Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AngioDynamics, Inc. - Common Stock
(NQ:
ANGO
)
10.50
-0.15 (-1.41%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 15, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AngioDynamics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI
January 13, 2025
From
AngioDynamics, Inc.
Via
Business Wire
Crude Oil Down 1%; US Weekly Jobless Claims Decline
January 08, 2025
Via
Benzinga
AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday
January 08, 2025
Via
Benzinga
AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
January 08, 2025
From
AngioDynamics, Inc.
Via
Business Wire
In-Depth Examination Of 4 Analyst Recommendations For AngioDynamics
December 10, 2024
Via
Benzinga
4 Analysts Assess AngioDynamics: What You Need To Know
October 04, 2024
Via
Benzinga
Earnings Scheduled For January 8, 2025
January 08, 2025
Via
Benzinga
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
January 06, 2025
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System
January 06, 2025
From
AngioDynamics, Inc.
Via
Business Wire
Limoneira And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
December 24, 2024
Via
Benzinga
AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event
December 19, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation
December 09, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System
October 23, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver
October 21, 2024
From
AngioDynamics, Inc.
Via
Business Wire
3 Stocks Insiders Are Buying Heavily In October 2024, And Why
October 09, 2024
Should investors add these stocks on their watchlist? Insider buys suggest so.
Via
Talk Markets
Nasdaq Moves Lower; Levi Strauss Shares Slide
October 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 03, 2024
Via
Benzinga
Crude Oil Jumps Over 4%; US Services PMI Revised Lower
October 03, 2024
Via
Benzinga
Why AngioDynamics Stock Is Crashing Today
October 03, 2024
Investors didn't like the medical technology company's fiscal 2025 Q1 update.
Via
The Motley Fool
AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday
October 03, 2024
Via
Benzinga
US Stocks Staring At Another Weak Open As Traders Await Key Jobs Report; Sentiment Wavers As Oil Extends Surge Amid Middle East Tensions
October 03, 2024
Sentiment continues to be cautious as traders play the “wait-and-watch” game until they see off Friday’s non-farm payroll data. The index futures traded moderately lower early Thursday.
Via
Benzinga
AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results
October 03, 2024
From
AngioDynamics, Inc.
Via
Business Wire
Top Wall Street Forecasters Revamp AngioDynamics Price Expectations Ahead Of Q1 Earnings
October 03, 2024
Via
Benzinga
S&P Settles Slightly Higher Despite Middle East Concerns: Fear Index Remains In 'Greed' Zone
October 03, 2024
Via
Benzinga
Topics
Stocks
Constellation Brands, Levi Strauss And 3 Stocks To Watch Heading Into Thursday
October 03, 2024
Via
Benzinga
AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes
September 19, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024
September 19, 2024
From
AngioDynamics, Inc.
Via
Business Wire
AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
September 03, 2024
From
AngioDynamics, Inc.
Via
Business Wire
PDD Holdings, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session
August 26, 2024
Via
Benzinga
AngioDynamics to Participate in Upcoming Investor Conferences
July 29, 2024
From
AngioDynamics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.